SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Director/PDMR Shareholding - Replacement

17 May 2016 17:06

RNS Number : 5228Y
Rentokil Initial PLC
17 May 2016
Β 

Β 

AMENDMENT

Changes made to boxes 20 and 22, amended figures are identified with an asterisk, and an explanation has been added in box 23.

Β 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

Β 

Notes: This form is intended for use by an issuer to make a RIS notification required by DTR 3.

Β 

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

Β 

Please complete all relevant boxes in block capital letters.

Β 

1. Name of the issuer

Β 

Rentokil Initial plc

Β 

2. State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance LR 9.8.6R(1) or(iii) a disclosure made in accordance with section 793 of the Companies Act (2006).

Β 

Pursuant to (i) above

Β 

3. Name of person discharging managerial responsibilities/director

Β 

i) Paul Cochrane (PDMR)

ii) Vanessa Evans (PDMR)

iii) JΓΌrgen HΣ§fling (PDMR)

iv) John Myers (PDMR)

v) Alain Moffroid (PDMR)

vi) Stewart Power (PDMR)

vii) Phill Wood (PDMR)

Β 

Β 

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

Β 

Not applicable

Β 

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

Β 

Pursuant to 3. above

Β 

6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

Β 

Ordinary shares of 1 pence each

Β 

7. Name of registered shareholder(s) and, if more than one, the number of shares held by each of them

Β 

Not applicable

Β 

8 State the nature of the transaction

Β 

Awards under the Performance Share Plan - 2016 award

Β 

9. Number of shares, debentures or financial instruments relating to shares acquired

Β 

Not applicable

Β 

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

Β 

Not applicable

Β 

11. Number of shares, debentures or financial instruments relating to shares disposed

Β 

Not applicable

Β 

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)Β 

Β 

Not applicable

Β 

13. Price per share or value of transaction

Β 

Not applicable

Β 

14. Date and place of transaction

Β 

Not applicable

Β 

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

Β 

Not applicable

Β 

16. Date issuer informed of transaction

Β 

Not applicable

Β 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

Β 

17. Date of grant

Β 

11 March 2016 - Performance Share Plan award 2016

Β 

18. Period during which or date on which it can be exercised

Β 

12 March 2019 to 10 March 2026 (subject to performance conditions)

Β 

19. Total amount paid (if any) for grant of the option

Β 

Nil

Β 

20. Description of shares or debentures involved (class and number)

Β 

Ordinary shares of 1 pence each

Β 

PSP 2016 Award1

Type of award

Paul Cochrane

85,406*

Performance share plan

Vanessa Evans

188,205*

Performance share plan

JΓΌrgen HΣ§fling

178,297*

Performance share plan

Alain Moffroid

97,195*

Performance share plan

John Myers

217,488*

Performance share plan

Stewart Power

156,538*

Performance share plan

Phill Wood

204,582*

Performance share plan

Β 

Notes

1Two-thirds of the award relate to relative TSR performance targets and one-third to EPS performance targets.

Β 

The awards to Andy Ransom and Jeremy Townsend for 2016 were not made until after the 2016 AGM, at which resolutions to revise the Remuneration Policy and to adopt updated Performance Share Plan Rules were submitted for shareholder approval.

Β 

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

Β 

Nil

Β 

22. Total number of shares or debentures over which options held following notification

Β 

Maximium award

Type of award

Paul Cochrane

85,406*

Performance share plan 2016

95,103

Performance share plan 2015

107,179

Performance share plan 2014

117,586

Performance share plan 2013

45,608

Performance share plan 2012 1

9,432

Performance share plan 2008 1

460,314

Total

Vanessa Evans

188,205*

Performance share plan 2016

196,720

Performance share plan 2015 2

384,925

Total

JΓΌrgen HΣ§fling

178,297*

Performance share plan 2016

228,069

Performance share plan 2015

406,366

Total

Alain Moffroid

97,195*

Performance share plan 2016

177,117

Performance share plan 2015

137,430

Performance share plan 2014

183,078

Performance share plan 2013

217,741

Performance share plan 2012 3

812,561

Total

John Myers

217,488*

Performance share plan 2016

217,759

Performance share plan 2015

154,116

Performance share plan 2014

199,848

Performance share plan 2013

64,961

Performance share plan 2008 1

854,172

Total

Stewart Power

156,538*

Performance share plan 2016

179,658

Performance share plan 2015

192,463

Performance share plan 2014

528,659

Total

Phill Wood

204,582*

Performance share plan 2016

238,284

Performance share plan 2015

255,267

Performance share plan 2014

165,980

Performance share plan 2013

64,734

Performance share plan 2012 1

928,847

Total

Β 

Notes

1 Unexercised but vested Performance share plan awards

2 Award on appointment under the Performance share plan 2015

3 Unexercised but vested compensatory share award on appointment under the Performance share plan 2012

Β 

23. Any additional information

Β 

This notification replaces the one dated 14 March 2016, which contained incorrect figures for the Performance share plan 2016 grant. The 2016 grant itself was made on 11 March 2016 on the correct basis, reflecting the amounts now shown correctly above, indicated with an asterisk.

Β 

24. Name of contact and telephone number for queries

Β 

Piotr Lasota, Company Secretarial Assistant - +44 (0)1276 607444

Β 

25. Name of authorised official of issuer responsible for making notification and date of notification

Β 

Daragh Fagan, Company Secretary - 17 May 2016

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHARMFTMBMBBIF
Date   Source Headline
28th Jul 20253:00 pmRNSHolding(s) in Company
10th Jul 202511:00 amRNSHolding(s) in Company
1st Jul 202510:25 amRNSTotal Voting Rights
10th Jun 202510:05 amRNSAdditional Listing
3rd Jun 20254:00 pmRNSDirector/PDMR Shareholding
28th May 20257:00 amRNSSale of France Workwear
19th May 20252:30 pmRNSDirector/PDMR Shareholding
7th May 20254:15 pmRNSResult of AGM
7th May 20257:01 amRNSDirectorate Change: Appointment of NEDs
7th May 20257:00 amRNSDirectorate Change: Chief Executive to retire
28th Apr 20252:30 pmRNSIssue of Debt
17th Apr 20252:20 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSQ1 Trading Update
9th Apr 202510:25 amRNSHolding(s) in Company
1st Apr 20252:15 pmRNSNotice of Q1 Trading Update and Management Call
1st Apr 202510:25 amRNSBlock listing Interim Review
27th Mar 202510:25 amRNSDirector/PDMR Shareholding
26th Mar 202510:30 amRNSAnnual Financial Report
14th Mar 202510:00 amRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFinal Results
28th Jan 20257:00 amRNSTrading Update (unaudited)
14th Jan 202511:15 amRNSHolding(s) in Company
13th Jan 202511:15 amRNSHolding(s) in Company
13th Dec 20249:30 amRNSDirector/PDMR Shareholding
25th Nov 20247:00 amRNSDirectorate Change
12th Nov 202410:30 amRNSHolding(s) in Company
8th Nov 202410:30 amRNSHolding(s) in Company
17th Oct 20247:00 amRNSQ3 Trading Update
1st Oct 20242:00 pmRNSBlock listing Interim Review
25th Sep 20247:00 amRNSAppointment of Non-Executive Director
19th Sep 202410:30 amRNSDirector/PDMR Shareholding
11th Sep 20247:00 amRNSTrading Update
10th Sep 202410:30 amRNSHolding(s) in Company
5th Sep 202411:08 amRNSHolding(s) in Company
25th Jul 20247:00 amRNS2024 Interim Results
10th Jul 20244:35 pmRNSHolding(s) in Company
26th Jun 20245:12 pmRNSDirector/PDMR Shareholding
26th Jun 202411:08 amRNSHolding(s) in Company
17th May 20243:30 pmRNSDirector/PDMR Shareholding
8th May 20242:00 pmRNSResult of AGM
29th Apr 20243:00 pmRNSHolding(s) in Company
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.